Quarterly Results

  • Company Name :
Zydus Lifesciences Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 532321
  • NSE Symbol:
  • ZYDUSLIFE
  • P/E(TTM):
  • 22.51
  • ISIN Demat:
  • INE010B01027
  • Div & Yield%:
  • 0.31
  • EPS(TTM):
  • 43.46
  • Book Value(₹):
  • 177.90
  • Market Cap(₹Cr.):
  • 98,434.84
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars December 2024 ( Cr)September 2024 ( Cr)June 2024 ( Cr)
Gross Sales 2,408.90 2,512.30 4,035.40
Excise Duty 0.00 0.00 0.00
Net Sales 2,408.90 2,512.30 4,035.40
Other Operating Income 107.00 108.30 124.80
Other Income 77.50 326.70 106.60
Total Income 2,593.40 2,947.30 4,266.80
Total Expenditure 1,867.40 1,678.40 1,787.30
PBIDT 726.00 1,268.90 2,479.50
Interest 97.20 95.90 115.40
PBDT 628.80 1,173.00 2,364.10
Depreciation 131.60 133.70 130.60
Tax -24.20 248.60 531.60
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 50.80 0.90 1.10
Reported Profit After Tax 470.60 789.80 1,700.80
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 470.60 789.80 1,700.80
EPS (Unit Curr.) 4.68 7.85 16.90
EPS (Adj) (Unit Curr.) 4.68 7.85 16.90
Calculated EPS (Unit Curr.) 4.68 7.85 16.91
Calculated EPS (Adj) (Unit Curr.) 4.68 7.85 16.91
Calculated EPS (Ann.) (Unit Curr.) 18.71 31.40 67.63
Calculated EPS (Adj) (Ann.) (Unit Curr.) 18.71 31.40 67.63
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 100.60 100.60 100.60
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 30.14 50.51 61.44
PBDTM(%) 26.10 46.69 58.58
PATM(%) 19.54 31.44 42.15